Round Table #3: Round Table #3: Virus Related Cancers
Room: Sorrell Room 2001
- Chair: Erich Sturgis, PhD, Baylor School of Medicine
- Co-chair: Anna Giuliano, PhD, H. Lee Moffit Cancer Center
- DMCC Statistician: Yingqi Zhao, PhD, Fred Hutchinson Cancer Center
- DMCC Staff: Suzanna Reid, PhD., Fred Hutchinson Cancer Center
- NIDCR PD: Amanda Melillo, PhD, National Institute of Dental and Craniofacial Research
- NCI PD: Wendy Wang, PhD, National Cancer Institute
Agenda
Suggested Discussion Points:
- Medical need for virus-related HNC early detection biomarkers.
- Limitations of existing HNC biomarkers and the need for improved sensitivity and specificity for early cancer detection.
- Epigenetic and transcriptomic changes in host cells induced by viruses as early indicators of cancerous transformations.
- Comparing biomarkers that are in discovery and in validation and how to evaluate these within the EDRN network of research.
- HPV-related cancers, HBV and HCV-related liver cancer, and EBV in cancer detection.
- Role of immune biomarkers in the early detection of virus-related cancers.
- Challenges and facilitators of the clinical translation of virus-related cancer biomarkers.
- Public health implications and prevention strategies.
- Inabilities/limitations for clinicians using current technologies to identify early HPV-related oropharyngeal cancers and EBV-related nasopharyngeal cancers before lymph node metastasis.
- Addressing vaccine hesitancy.
- Increasing Hep C and HIV screening efforts.